amifostine trihydrate [clinicaltrials_resource:e8dd3157ad91c0b9407e176e24ad6b51]
High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast Cancer [clinicaltrials:NCT00003068]Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer [clinicaltrials:NCT00003072]Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer [clinicaltrials:NCT00003089]Amifostine in Treating Patients With Advanced Myelodysplastic Syndrome [clinicaltrials:NCT00003123]Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003144]Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer [clinicaltrials:NCT00003251]Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy [clinicaltrials:NCT00003252]Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia [clinicaltrials:NCT00003268]Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors [clinicaltrials:NCT00003269]Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer [clinicaltrials:NCT00003294]Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer [clinicaltrials:NCT00003307]Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia [clinicaltrials:NCT00003405]Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia [clinicaltrials:NCT00003407]Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003415]Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors [clinicaltrials:NCT00003555]Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer [clinicaltrials:NCT00003580]Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer [clinicaltrials:NCT00003582]Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer [clinicaltrials:NCT00003583]Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [clinicaltrials:NCT00003624]Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer [clinicaltrials:NCT00003657]Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003681]Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer [clinicaltrials:NCT00003777]Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors [clinicaltrials:NCT00003811]Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003827]Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer [clinicaltrials:NCT00004036]Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy [clinicaltrials:NCT00004166]Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer [clinicaltrials:NCT00004176]Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung Cancer [clinicaltrials:NCT00004264]Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00005598]Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx [clinicaltrials:NCT00025298]Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer [clinicaltrials:NCT00058071]Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes [clinicaltrials:NCT00098683]
intervention [clinicaltrials_vocabulary:intervention]
amifostine trihydrate [clinicaltrials_resource:e8dd3157ad91c0b9407e176e24ad6b51]
Bio2RDF identifier
e8dd3157ad91c0b9407e176e24ad6b51
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e8dd3157ad91c0b9407e176e24ad6b51
intervention name [clinicaltrials_vocabulary:intervention-name]
amifostine trihydrate
identifier
clinicaltrials_resource:e8dd3157ad91c0b9407e176e24ad6b51
title
amifostine trihydrate
@en
type
label
amifostine trihydrate [clinicaltrials_resource:e8dd3157ad91c0b9407e176e24ad6b51]
@en